Data at 36 months for the Symplicity SPYRAL HTN-ON MED pilot

Lancet. 2022 Aug 13;400(10351):491-492. doi: 10.1016/S0140-6736(22)01471-4.

Authors

Eric M Snyder¹, Ryan Sprissler², Thomas P Olson³

Affiliations

¹ Geneticure, Rochester, MN, 55902, USA. Electronic address: eric@geneticure.com.
² Geneticure, Rochester, MN, 55902, USA; Department of Medicine, University of Arizona Genomics Core, University of Arizona, Tucson, AZ, USA.
³ Geneticure, Rochester, MN, 55902, USA; Disivion of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.

PMID: 35964607
DOI: 10.1016/S0140-6736(22)01471-4

No abstract available

Publication types

Letter
Comment

MeSH terms

Antihypertensive Agents* / therapeutic use
Humans
Sympathectomy*

Substances

Antihypertensive Agents